200 related articles for article (PubMed ID: 34684735)
1.
Eissa IH; Khalifa MM; Elkaeed EB; Hafez EE; Alsfouk AA; Metwaly AM
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684735
[TBL] [Abstract][Full Text] [Related]
2. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-
Eissa IH; Alesawy MS; Saleh AM; Elkaeed EB; Alsfouk BA; El-Attar AMM; Metwaly AM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408684
[TBL] [Abstract][Full Text] [Related]
3. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
[TBL] [Abstract][Full Text] [Related]
4. Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2.
El-Demerdash A; Hassan A; Abd El-Aziz TM; Stockand JD; Arafa RK
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684755
[TBL] [Abstract][Full Text] [Related]
5. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
8. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
[TBL] [Abstract][Full Text] [Related]
9. Jusanin, a New Flavonoid from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268738
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
[TBL] [Abstract][Full Text] [Related]
11. Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking.
Vique-Sánchez JL
Bioorg Med Chem; 2021 Mar; 33():116040. PubMed ID: 33515918
[TBL] [Abstract][Full Text] [Related]
12. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
13. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
Saramago M; Bárria C; Costa VG; Souza CS; Viegas SC; Domingues S; Lousa D; Soares CM; Arraiano CM; Matos RG
FEBS J; 2021 Sep; 288(17):5130-5147. PubMed ID: 33705595
[TBL] [Abstract][Full Text] [Related]
14. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
[TBL] [Abstract][Full Text] [Related]
15. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.
Canal B; McClure AW; Curran JF; Wu M; Ulferts R; Weissmann F; Zeng J; Bertolin AP; Milligan JC; Basu S; Drury LS; Deegan TD; Fujisawa R; Roberts EL; Basier C; Labib K; Beale R; Howell M; Diffley JFX
Biochem J; 2021 Jul; 478(13):2445-2464. PubMed ID: 34198326
[TBL] [Abstract][Full Text] [Related]
16. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex.
Chen J; Zhou Y; Wei X; Xu X; Qin Z; Ong CP; Ye ZW; Jin DY; Boitrel B; Yuan S; Chan JF; Li H; Sun H
ACS Infect Dis; 2024 Mar; 10(3):858-869. PubMed ID: 37897418
[TBL] [Abstract][Full Text] [Related]
17. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
[TBL] [Abstract][Full Text] [Related]
18. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
Lin S; Chen H; Ye F; Chen Z; Yang F; Zheng Y; Cao Y; Qiao J; Yang S; Lu G
Signal Transduct Target Ther; 2020 Jul; 5(1):131. PubMed ID: 32728018
[No Abstract] [Full Text] [Related]
20. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease.
Elkaeed EB; Youssef FS; Eissa IH; Elkady H; Alsfouk AA; Ashour ML; El Hassab MA; Abou-Seri SM; Metwaly AM
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
